Skip to main content
Erschienen in: Molecular Imaging and Biology 2/2019

21.06.2018 | Research Article

Associations Between [18F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1α, and p53 in Head and Neck Squamous Cell Carcinoma

verfasst von: Alexey Surov, Hans Jonas Meyer, Anne-Kathrin Höhn, Karsten Winter, Osama Sabri, Sandra Purz

Erschienen in: Molecular Imaging and Biology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Head and neck squamous cell carcinoma (HNSCC) is one of common cancers worldwide. Positron emission tomography (PET) with 2-deoxy-2-[18F]fluoro-d-glucose ([18F]FDG) is increasingly used for diagnosing and staging, as well as for monitoring of treatment of HNSCC. PET parameters like maximum and mean standard uptake values (SUVmax, SUVmean) can predict the behavior of HNSCC. The purpose of this study was to analyze possible associations between these PET parameters and clinically relevant histopathological features in patients with HNSCC.

Procedures

Overall, 22 patients, mean age, 55.2 ± 11.0 years, with different HNSCC were acquired. Low grade (G1/2) tumors were diagnosed in 10 cases (45 %) and high grade (G3) tumor in 12 (55 %) patients. In all cases, whole body PET was performed. For this study, the following specimen stainings were performed: MIB-1 staining (KI 67 expression), epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF), tumor suppressor protein p53, hypoxia-inducible factor (HIF)-1α, and human papilloma virus (p16 expression). All stained specimens were digitalized and analyzed by using the ImageJ software 1.48v. Spearman’s correlation coefficient (ρ) was used to analyze associations between investigated parameters. P values <0.05 were taken to indicate statistical significance.

Results

P16-negative tumors showed statistically significant higher SUVmax (ρ = 0.006) and SUVmean values (ρ = 0.002) in comparison to p16-positive carcinomas. No significant differences were identified in the analyzed parameters between poorly and moderately/well-differentiated tumors. In overall sample, there were no statistically significant correlations between the [18F]FDG-PET and histopathological parameters. Also, in G1/2 tumors, no significant correlations were identified. In G3 carcinomas, cell count correlated statistical significant with SUVmax (p = 0.580, P = 0.048) and SUVmean (ρ = 0.587, P = 0.045).

Conclusion

Associations between [18F]FDG-PET parameters and different histopathological features in HNSCC depend significantly on tumor grading. In G1/2 carcinomas, there were no significant correlations between [18F]FDG-PET parameters and histopathology. In G3 lesions, SUVmax and SUVmean reflect tumor cellularity.
Literatur
1.
Zurück zum Zitat Braakhuis BJ, Leemans CR, Visser O (2014) Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral Oncol 50:670–675CrossRefPubMed Braakhuis BJ, Leemans CR, Visser O (2014) Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral Oncol 50:670–675CrossRefPubMed
2.
Zurück zum Zitat Adams S, Baum RP, Stuckensen T, Bitter K, Hör G (1998) Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 25:1255–1260CrossRefPubMed Adams S, Baum RP, Stuckensen T, Bitter K, Hör G (1998) Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 25:1255–1260CrossRefPubMed
3.
Zurück zum Zitat Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF (2005) 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 46:1136–1143PubMed Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF (2005) 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 46:1136–1143PubMed
4.
Zurück zum Zitat Surov A, Stumpp P, Meyer HJ, Gawlitza M, Höhn AK, Boehm A, Sabri O, Kahn T, Purz S (2016) Simultaneous 18F-FDG-PET/MRI: associations between diffusion, glucose metabolism and histopathological parameters in patients with head and neck squamous cell carcinoma. Oral Oncol 58:14–20CrossRefPubMed Surov A, Stumpp P, Meyer HJ, Gawlitza M, Höhn AK, Boehm A, Sabri O, Kahn T, Purz S (2016) Simultaneous 18F-FDG-PET/MRI: associations between diffusion, glucose metabolism and histopathological parameters in patients with head and neck squamous cell carcinoma. Oral Oncol 58:14–20CrossRefPubMed
5.
Zurück zum Zitat Varoquaux A, Rager O, Poncet A, Delattre BMA, Ratib O, Becker CD, Dulguerov P, Dulguerov N, Zaidi H, Becker M (2014) Detection and quantification of focal uptake in head and neck tumours: 18F-FDG PET/MR versus PET/CT. Eur J Nucl Med Mol Imaging 41:462–475CrossRefPubMed Varoquaux A, Rager O, Poncet A, Delattre BMA, Ratib O, Becker CD, Dulguerov P, Dulguerov N, Zaidi H, Becker M (2014) Detection and quantification of focal uptake in head and neck tumours: 18F-FDG PET/MR versus PET/CT. Eur J Nucl Med Mol Imaging 41:462–475CrossRefPubMed
6.
Zurück zum Zitat Goel R, Moore W, Sumer B, Khan S, Sher D, Subramaniam RM (2017) Clinical practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer. AJR Am J Roentgenol 209:289–303CrossRefPubMed Goel R, Moore W, Sumer B, Khan S, Sher D, Subramaniam RM (2017) Clinical practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer. AJR Am J Roentgenol 209:289–303CrossRefPubMed
7.
Zurück zum Zitat Chan SC, Cheng NM, Hsieh CH, Ng SH, Lin CY, Yen TC, Hsu CL, Wan HM, Liao CT, Chang KP, Wang JJ (2017) Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. Oncotarget 8:62606–62621PubMedPubMedCentral Chan SC, Cheng NM, Hsieh CH, Ng SH, Lin CY, Yen TC, Hsu CL, Wan HM, Liao CT, Chang KP, Wang JJ (2017) Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. Oncotarget 8:62606–62621PubMedPubMedCentral
8.
Zurück zum Zitat Ryu IS, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY (2016) Impact of 18F -FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: a prospective observational study. Eur J Cancer 63:88–96CrossRefPubMed Ryu IS, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY (2016) Impact of 18F -FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: a prospective observational study. Eur J Cancer 63:88–96CrossRefPubMed
9.
Zurück zum Zitat Haerle SK, Huber GF, Hany TF, Ahmad N, Schmid DT (2010) Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck? Eur Arch Otorhinolaryngol 267:1635–1640CrossRefPubMed Haerle SK, Huber GF, Hany TF, Ahmad N, Schmid DT (2010) Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck? Eur Arch Otorhinolaryngol 267:1635–1640CrossRefPubMed
10.
Zurück zum Zitat Kendi AT, Corey A, Magliocca KR, Nickleach DC, Galt J, Switchenko JM, el-Deiry MW, Wadsworth JT, Hudgins PA, Saba NF, Schuster DM (2015) 18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers? Eur J Radiol 84:1171–1176CrossRefPubMedPubMedCentral Kendi AT, Corey A, Magliocca KR, Nickleach DC, Galt J, Switchenko JM, el-Deiry MW, Wadsworth JT, Hudgins PA, Saba NF, Schuster DM (2015) 18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers? Eur J Radiol 84:1171–1176CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Li SJ, Guo W, Ren GX, Huang G, Chen T, Song SL (2008) Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography. Br J Oral Maxillofac Surg 46:180–186CrossRefPubMed Li SJ, Guo W, Ren GX, Huang G, Chen T, Song SL (2008) Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography. Br J Oral Maxillofac Surg 46:180–186CrossRefPubMed
12.
Zurück zum Zitat Abgral R, Keromnes N, Robin P, le Roux PY, Bourhis D, Palard X, Rousset J, Valette G, Marianowski R, Salaün PY (2014) Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma. Eur J Nucl Med Mol Imaging 41:659–667CrossRefPubMed Abgral R, Keromnes N, Robin P, le Roux PY, Bourhis D, Palard X, Rousset J, Valette G, Marianowski R, Salaün PY (2014) Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma. Eur J Nucl Med Mol Imaging 41:659–667CrossRefPubMed
13.
Zurück zum Zitat Kim SY, Roh JL, Kim JS, Ryu CH, Lee JH, Cho KJ, Choi SH, Nam SY (2008) Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity. Eur J Surg Oncol 34:208–215CrossRefPubMed Kim SY, Roh JL, Kim JS, Ryu CH, Lee JH, Cho KJ, Choi SH, Nam SY (2008) Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity. Eur J Surg Oncol 34:208–215CrossRefPubMed
14.
Zurück zum Zitat Kitagawa Y, Sano K, Nishizawa S, Nakamura M, Ogasawara T, Sadato N, Yonekura Y (2003) FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 30:63–71CrossRefPubMed Kitagawa Y, Sano K, Nishizawa S, Nakamura M, Ogasawara T, Sadato N, Yonekura Y (2003) FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 30:63–71CrossRefPubMed
15.
Zurück zum Zitat Wong KH, Panek R, Welsh L, Mcquaid D, Dunlop A, Riddell A, Murray I, du Y, Chua S, Koh DM, Bhide S, Nutting C, Oyen WJG, Harrington K, Newbold KL (2016) The predictive value of early assessment after 1 cycle of induction chemotherapy with 18F-FDG PET/CT and diffusion-weighted MRI for response to radical chemoradiotherapy in head and neck squamous cell carcinoma. J Nucl Med 57:1843–1850CrossRefPubMed Wong KH, Panek R, Welsh L, Mcquaid D, Dunlop A, Riddell A, Murray I, du Y, Chua S, Koh DM, Bhide S, Nutting C, Oyen WJG, Harrington K, Newbold KL (2016) The predictive value of early assessment after 1 cycle of induction chemotherapy with 18F-FDG PET/CT and diffusion-weighted MRI for response to radical chemoradiotherapy in head and neck squamous cell carcinoma. J Nucl Med 57:1843–1850CrossRefPubMed
16.
Zurück zum Zitat Rasmussen GB, Vogelius IR, Rasmussen JH, Schumaker L, Ioffe O, Cullen K, Fischer BM, Therkildsen MH, Specht L, Bentzen SM (2015) Immunohistochemical biomarkers and FDG uptake on PET/CT in head and neck squamous cell carcinoma. Acta Oncol 54:1408–1415CrossRefPubMed Rasmussen GB, Vogelius IR, Rasmussen JH, Schumaker L, Ioffe O, Cullen K, Fischer BM, Therkildsen MH, Specht L, Bentzen SM (2015) Immunohistochemical biomarkers and FDG uptake on PET/CT in head and neck squamous cell carcinoma. Acta Oncol 54:1408–1415CrossRefPubMed
17.
Zurück zum Zitat Troy JD, Weissfeld JL, Youk AO, Thomas S, Wang L, Grandis JR (2013) Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPV-positive and HPV-negative head and neck squamous cell carcinoma. Head Neck Pathol 7:344–355CrossRefPubMedPubMedCentral Troy JD, Weissfeld JL, Youk AO, Thomas S, Wang L, Grandis JR (2013) Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPV-positive and HPV-negative head and neck squamous cell carcinoma. Head Neck Pathol 7:344–355CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Grönroos TJ, Lehtiö K, Söderström KO, Kronqvist P, Laine J, Eskola O, Viljanen T, Grénman R, Solin O, Minn H (2014) Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET. BMC Cancer 14:876CrossRefPubMedPubMedCentral Grönroos TJ, Lehtiö K, Söderström KO, Kronqvist P, Laine J, Eskola O, Viljanen T, Grénman R, Solin O, Minn H (2014) Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET. BMC Cancer 14:876CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Zhao K, Yang SY, Zhou SH et al (2014) Fluorodeoxyglucose uptake in laryngeal carcinoma is associated with the expression of glucose transporter 1 and hypoxia inducible factor 1α and the phosphoinositide 3 kinase/protein kinase B pathway. Oncol Lett 7:984–990CrossRefPubMedPubMedCentral Zhao K, Yang SY, Zhou SH et al (2014) Fluorodeoxyglucose uptake in laryngeal carcinoma is associated with the expression of glucose transporter 1 and hypoxia inducible factor 1α and the phosphoinositide 3 kinase/protein kinase B pathway. Oncol Lett 7:984–990CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Han MW, Lee HJ, Cho KJ, Kim JS, Roh JL, Choi SH, Nam SY, Kim SY (2012) Role of FDG-PET as a biological marker for predicting the hypoxic status of tongue cancer. Head Neck 34:1395–1402CrossRefPubMed Han MW, Lee HJ, Cho KJ, Kim JS, Roh JL, Choi SH, Nam SY, Kim SY (2012) Role of FDG-PET as a biological marker for predicting the hypoxic status of tongue cancer. Head Neck 34:1395–1402CrossRefPubMed
21.
Zurück zum Zitat Surov A, Gottschling S, Mawrin C, Prell J, Spielmann RP, Wienke A, Fiedler E (2015) Diffusion weighted imaging in meningioma: prediction of tumor grade and association with histopathological parameters. Transl Oncol 8:517–523CrossRefPubMedPubMedCentral Surov A, Gottschling S, Mawrin C, Prell J, Spielmann RP, Wienke A, Fiedler E (2015) Diffusion weighted imaging in meningioma: prediction of tumor grade and association with histopathological parameters. Transl Oncol 8:517–523CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Surov A, Caysa H, Wienke A, Spielmann RP, Fiedler E (2015) Correlation between different ADC fractions, cell count, Ki-67, total nucleic areas and average nucleic areas in meningothelial meningiomas. Anticancer Res 35:6841–6846PubMed Surov A, Caysa H, Wienke A, Spielmann RP, Fiedler E (2015) Correlation between different ADC fractions, cell count, Ki-67, total nucleic areas and average nucleic areas in meningothelial meningiomas. Anticancer Res 35:6841–6846PubMed
23.
Zurück zum Zitat Doll CM, Moughan J, Klimowicz A, Ho CK, Kornaga EN, Lees-Miller SP, Ajani JA, Crane CH, Kachnic LA, Okawara GS, Berk LB, Roof KS, Becker MJ, Grisell DL, Ellis RJ, Sperduto PW, Marsa GW, Guha C, Magliocco AM (2017) Significance of co-expression of epidermal growth factor receptor and Ki67 on clinical outcome in patients with anal cancer treated with chemoradiotherapy: an analysis of NRG oncology RTOG 9811. Int J Radiat Oncol Biol Phys 97:554–562CrossRefPubMed Doll CM, Moughan J, Klimowicz A, Ho CK, Kornaga EN, Lees-Miller SP, Ajani JA, Crane CH, Kachnic LA, Okawara GS, Berk LB, Roof KS, Becker MJ, Grisell DL, Ellis RJ, Sperduto PW, Marsa GW, Guha C, Magliocco AM (2017) Significance of co-expression of epidermal growth factor receptor and Ki67 on clinical outcome in patients with anal cancer treated with chemoradiotherapy: an analysis of NRG oncology RTOG 9811. Int J Radiat Oncol Biol Phys 97:554–562CrossRefPubMed
24.
Zurück zum Zitat Almangush A, Heikkinen I, Mäkitie AA, Coletta RD, Läärä E, Leivo I, Salo T (2017) Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis. Br J Cancer 117:856–866CrossRefPubMedPubMedCentral Almangush A, Heikkinen I, Mäkitie AA, Coletta RD, Läärä E, Leivo I, Salo T (2017) Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis. Br J Cancer 117:856–866CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Gioacchini FM, Alicandri-Ciufelli M, Magliulo G, Rubini C, Presutti L, Re M (2015) The clinical relevance of Ki-67 expression in laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 272:1569–1576CrossRefPubMed Gioacchini FM, Alicandri-Ciufelli M, Magliulo G, Rubini C, Presutti L, Re M (2015) The clinical relevance of Ki-67 expression in laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 272:1569–1576CrossRefPubMed
26.
Zurück zum Zitat Oliveira LR, Ribeiro-Silva A (2011) Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 40:298–307CrossRefPubMed Oliveira LR, Ribeiro-Silva A (2011) Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 40:298–307CrossRefPubMed
27.
Zurück zum Zitat Bossi P, Resteghini C, Paielli N, Licitra L, Pilotti S, Perrone F (2016) Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma. Oncotarget 7:74362–74379CrossRefPubMedPubMedCentral Bossi P, Resteghini C, Paielli N, Licitra L, Pilotti S, Perrone F (2016) Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma. Oncotarget 7:74362–74379CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Ma X, Huang J, Wu X, Li X, Zhang J, Xue L, Li P, Liu L (2014) Epidermal growth factor receptor could play a prognostic role to predict the outcome of nasopharyngeal carcinoma: a meta-analysis. Cancer Biomark 14:267–277CrossRefPubMed Ma X, Huang J, Wu X, Li X, Zhang J, Xue L, Li P, Liu L (2014) Epidermal growth factor receptor could play a prognostic role to predict the outcome of nasopharyngeal carcinoma: a meta-analysis. Cancer Biomark 14:267–277CrossRefPubMed
29.
Zurück zum Zitat Tandon S, Tudur-Smith C, Riley RD, Boyd MT, Jones TM (2010) A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck. Cancer Epidemiol Biomark Prev 19:574–587CrossRef Tandon S, Tudur-Smith C, Riley RD, Boyd MT, Jones TM (2010) A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck. Cancer Epidemiol Biomark Prev 19:574–587CrossRef
30.
Zurück zum Zitat Zang J, Li C, Zhao LN, Shi M, Zhou YC, Wang JH, Li X (2013) Prognostic value of vascular endothelial growth factor in patients with head and neck cancer: a meta-analysis. Head Neck 35:1507–1514PubMed Zang J, Li C, Zhao LN, Shi M, Zhou YC, Wang JH, Li X (2013) Prognostic value of vascular endothelial growth factor in patients with head and neck cancer: a meta-analysis. Head Neck 35:1507–1514PubMed
31.
Zurück zum Zitat Melkane AE, Auperin A, Saulnier P, Lacroix L, Vielh P, Casiraghi O, Msakni I, Drusch F, Temam S (2014) Human papillomavirus prevalence and prognostic implication in oropharyngeal squamous cell carcinomas. Head Neck 36:257–265CrossRefPubMed Melkane AE, Auperin A, Saulnier P, Lacroix L, Vielh P, Casiraghi O, Msakni I, Drusch F, Temam S (2014) Human papillomavirus prevalence and prognostic implication in oropharyngeal squamous cell carcinomas. Head Neck 36:257–265CrossRefPubMed
32.
Zurück zum Zitat Gong L, Zhang W, Zhou J, Lu J, Xiong H, Shi X, Chen J (2013) Prognostic value of HIFs expression in head and neck cancer: a systematic review. PLoS ON 8:e75094CrossRef Gong L, Zhang W, Zhou J, Lu J, Xiong H, Shi X, Chen J (2013) Prognostic value of HIFs expression in head and neck cancer: a systematic review. PLoS ON 8:e75094CrossRef
33.
Zurück zum Zitat Yokobori Y, Toyoda M, Sakakura K, Kaira K, Tsushima Y, Chikamatsu K (2015) 18F-FDG uptake on PET correlates with biological potential in early oral squamous cell carcinoma. Acta Otolaryngol 135:494–499CrossRefPubMed Yokobori Y, Toyoda M, Sakakura K, Kaira K, Tsushima Y, Chikamatsu K (2015) 18F-FDG uptake on PET correlates with biological potential in early oral squamous cell carcinoma. Acta Otolaryngol 135:494–499CrossRefPubMed
34.
Zurück zum Zitat Deron P, Vangestel C, Goethals I, de Potter A, Peeters M, Vermeersch H, van de Wiele C (2011) FDG uptake in primary squamous cellcarcinoma of the head and neck. The relationship between over expression of glucose transporters and hexokinases, tumour proliferation and apoptosis. Nuklearmedizin 50:15–21PubMed Deron P, Vangestel C, Goethals I, de Potter A, Peeters M, Vermeersch H, van de Wiele C (2011) FDG uptake in primary squamous cellcarcinoma of the head and neck. The relationship between over expression of glucose transporters and hexokinases, tumour proliferation and apoptosis. Nuklearmedizin 50:15–21PubMed
35.
Zurück zum Zitat Jacob R, Welkoborsky HJ, Mann WJ, Jauch M, Amedee R (2001) [Fluorine-18] Fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck. ORL 63:307–313CrossRefPubMed Jacob R, Welkoborsky HJ, Mann WJ, Jauch M, Amedee R (2001) [Fluorine-18] Fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck. ORL 63:307–313CrossRefPubMed
36.
Zurück zum Zitat Norikane T, Yamamoto Y, Maeda Y, Kudomi N, Matsunaga T, Haba R, Iwasaki A, Hoshikawa H, Nishiyama Y (2014) Correlation of (18)F-fluoromisonidazole PET findings with HIF-1α and p53 expressions in head and neck cancer: comparison with 18F-FDG PET. Nucl Med Commun 35:30–35CrossRefPubMed Norikane T, Yamamoto Y, Maeda Y, Kudomi N, Matsunaga T, Haba R, Iwasaki A, Hoshikawa H, Nishiyama Y (2014) Correlation of (18)F-fluoromisonidazole PET findings with HIF-1α and p53 expressions in head and neck cancer: comparison with 18F-FDG PET. Nucl Med Commun 35:30–35CrossRefPubMed
37.
Zurück zum Zitat Leifels L, Purz S, Stumpp P, Schob S, Meyer HJ, Kahn T, Sabri O, Surov A (2017) Associations between 18F-FDG-PET, DWI, and DCE parameters in patients with head and neck squamous cell carcinoma depend on tumor grading. Contrast Media Mol Imaging 5369625 Leifels L, Purz S, Stumpp P, Schob S, Meyer HJ, Kahn T, Sabri O, Surov A (2017) Associations between 18F-FDG-PET, DWI, and DCE parameters in patients with head and neck squamous cell carcinoma depend on tumor grading. Contrast Media Mol Imaging 5369625
38.
Zurück zum Zitat Wadhwan V, Sharma P, Saxena C et al (2015) Grading angiogenesis in oral squamous cell carcinoma: a histomorphometric study. Indian J Dent Res 26:26–30CrossRefPubMed Wadhwan V, Sharma P, Saxena C et al (2015) Grading angiogenesis in oral squamous cell carcinoma: a histomorphometric study. Indian J Dent Res 26:26–30CrossRefPubMed
39.
Zurück zum Zitat Anneroth G, Hansen LS (1984) A methodologic study of histologic classification and grading of malignancy in oral squamous cell carcinoma. Scand J Dent Res 92:448–468PubMed Anneroth G, Hansen LS (1984) A methodologic study of histologic classification and grading of malignancy in oral squamous cell carcinoma. Scand J Dent Res 92:448–468PubMed
40.
Zurück zum Zitat Schouten CS, Hakim S, Boellaard R, Bloemena E, Doornaert PA, Witte BI, Braakhuis BJM, Brakenhoff RH, Leemans CR, Hoekstra OS, de Bree R (2016) Interaction of quantitative 18F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma. Head Neck 38:529–535CrossRefPubMed Schouten CS, Hakim S, Boellaard R, Bloemena E, Doornaert PA, Witte BI, Braakhuis BJM, Brakenhoff RH, Leemans CR, Hoekstra OS, de Bree R (2016) Interaction of quantitative 18F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma. Head Neck 38:529–535CrossRefPubMed
Metadaten
Titel
Associations Between [18F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1α, and p53 in Head and Neck Squamous Cell Carcinoma
verfasst von
Alexey Surov
Hans Jonas Meyer
Anne-Kathrin Höhn
Karsten Winter
Osama Sabri
Sandra Purz
Publikationsdatum
21.06.2018
Verlag
Springer International Publishing
Erschienen in
Molecular Imaging and Biology / Ausgabe 2/2019
Print ISSN: 1536-1632
Elektronische ISSN: 1860-2002
DOI
https://doi.org/10.1007/s11307-018-1223-x

Weitere Artikel der Ausgabe 2/2019

Molecular Imaging and Biology 2/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.